Share

    


Home / Search Results

Search Results

You searched for:

    Displaying results 1 - 20 of 100
  • 1
  • 2
  • 3
  • 4
  • 5
  • »
LUNGevity invited ACCC and other stakeholders across the oncology world to Washington DC, for their second Health Equity Summit on Tuesday, March 12.
ACCC recognizes April as National Cancer Prevention and Early Detection Month.
Explore findings from a multi-stakeholder collaboration aimed at exploring clinical meaningfulness in comprehensive care delivery for patients with metastatic breast cancer.
Explore key takeaways from a meeting between ACCC, Inova Schar Cancer Institute, and delegates from the Swedish Ministry of Health and Social Affairs.
Highlights from the final day of the ACCC 50th Annual Meeting & Cancer Center Business Summit (#AMCCBS).
Oncology Hematology Care, Inc. launched a one-year quality improvement project to implement and standardize comprehensive biomarker testing in patients with metastatic non-small cell lung cancer.
Evaluate recommendations on improving clinical trial diversity among patients with acute myeloid leukemia.
This is the second post of a three-part series on Modern Healthcare’s Social Determinants of Health Symposium.
ACCC, ACS CAN, and LUNGevity, launched a series of focus groups earlier this year aimed at making the case for increasing access to comprehensive genomic profiling for Medicaid beneficiaries.
CAR T-cell therapies have ushered in a new era of treatment options for patients with certain hematologic malignancies. Thus, it is important to make these therapies accessible and affordable.
At the ACCC 40th NOC, an exclusive EHR Working Summit was held to understand and explore effective practices/workaround solutions for streamlined biomarker test ordering and results management.
Equitable access to precision medicine should be a right to which all patients with cancer are entitled regardless of their insurance coverage or type. Read more about ACCC’s efforts to help Medicaid beneficiaries overcome financial barriers to biomarker testing.
ACCC in partnership with HealthTree Foundation for Acute Myeloid Leukemia, has launched an education program to explore the current barriers in care coordination and therapy options for patients with AML who are not eligible for transplant.
ACCC president Olalekan Ajayi, PharmD, MBA, shared the association’s key priorities for impacting cancer care in the United States with the President’s Cancer Panel.
Let’s Win Pancreatic Cancer provides a road map of resources to help newly diagnosed patients with pancreatic cancer obtain the resources they need throughout their care journey.
A deep dive into 4 topics discussed during a series of interactive sessions at the ACCC 49th Annual Meeting and Cancer Center Business Summit: business and artificial intelligence technology, research and clinical trials, and precision medicine.
Actionable strategies for coordinating RECIST 1.1 at a community hospital.
Adopting a human-centered approach to designing clinical trials that considers the preferences and experiences of rural patients with cancer and providers could increase patient enrollment and close care gaps.
Through a series of education projects, ACCC is committed to providing the resources the multidisciplinary cancer care team will need to navigate the complex precision medicine landscape and deliver next generation cancer care.
In the era of personalized medicine, biomarker testing is a tool the oncology workforce can and should leverage to deliver next generation cancer care.
    Displaying results 1 - 20 of 100
  • 1
  • 2
  • 3
  • 4
  • 5
  • »